Stockscreener 앱 받기
2.46
2.77%
-0.07
시간 외 거래:
2.46
전일 마감가:
$2.53
열려 있는:
$2.51
하루 거래량:
303.20K
Relative Volume:
1.35
시가총액:
$123.98M
수익:
$81.06M
순이익/손실:
$-55.55M
주가수익비율:
-2.1579
EPS:
-1.14
순현금흐름:
$-47.98M
1주 성능:
-10.22%
1개월 성능:
-16.04%
6개월 성능:
-63.61%
1년 성능:
-44.47%
1일 변동 폭
$2.45
$2.61
1주일 범위
$2.45
$2.87
52주 변동 폭
$2.45
$8.45
Sight Sciences Inc Stock (SGHT) Company Profile
명칭
Sight Sciences Inc
전화
(415) 889-0550
주소
4040 CAMPBELL AVE,, MENLO PARK
SGHT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
2.46 | 123.98M | 81.06M | -55.55M | -47.98M | -1.14 |
|
ABT
Abbott Laboratories
|
134.95 | 234.06B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.39 | 154.06B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
387.92 | 148.02B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.17 | 115.71B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.76 | 42.91B | 5.72B | 4.17B | 490.10M | 6.97 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-06 | 개시 | UBS | Buy |
| 2024-11-04 | 다운그레이드 | Lake Street | Buy → Hold |
| 2024-08-21 | 개시 | Lake Street | Buy |
| 2023-09-12 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-09-12 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-09-12 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-08-24 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-01-06 | 업그레이드 | Stifel | Hold → Buy |
| 2022-10-04 | 개시 | Needham | Hold |
| 2022-07-26 | 개시 | Stifel | Hold |
| 2022-02-03 | 개시 | William Blair | Outperform |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
모두보기
Sight Sciences Inc 주식(SGHT)의 최신 뉴스
Sight Sciences stock hits 52-week low at $2.47 amid market challenges - Investing.com Nigeria
Sight Sciences to Present Comprehensive Clinical Data on - GlobeNewswire
Can This Groundbreaking Glaucoma Treatment Transform Patient Care? New Data Reveals 3-Year Outcomes - StockTitan
Sight Sciences stock hits 52-week low at $2.47 amid market challenges By Investing.com - Investing.com South Africa
Critical Contrast: Microbot Medical (NASDAQ:MBOT) vs. Sight Sciences (NASDAQ:SGHT) - Defense World
Sight Sciences to Report Fourth Quarter and Full Year 2024 Financial Results on March 5, 2025 - The Manila Times
Can Sight Sciences Maintain Growth Momentum? Q4 Earnings Date Revealed - StockTitan
Analysts Set Sight Sciences, Inc. (NASDAQ:SGHT) Target Price at $4.68 - MarketBeat
Sight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Rating of “Hold” from Analysts - Defense World
Stifel maintains Buy rating and $5 target on Sight Sciences stock - Investing.com Australia
Stifel maintains Buy rating and $5 target on Sight Sciences stock By Investing.com - Investing.com South Africa
Sight sciences CTO David Badawi sells $15,081 in stock - MSN
Sight Sciences stock hits 52-week low at $2.54 amid market challenges - MSN
SG Americas Securities LLC Grows Stake in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World
Sight Sciences to Present at Citi’s 2025 Unplugged MedTech and Life Sciences Access Day - GlobeNewswire
Sight Sciences to Present at Citi's 2025 Unplugged MedTech and Life Sciences Access Day - The Manila Times
Exclusive: Sight Sciences to Unveil Latest Eye Care Innovation Strategy at Major Citi Conference - StockTitan
Sight Sciences stock hits 52-week low at $2.54 amid market challenges By Investing.com - Investing.com South Africa
Raymond James downgrades Third Harmonic Bio on uncertainty for only asset - MSN
Ivanhoe Electric shares fall on public offering of units - MSN
Amarc to acquire 100% interest in adjacent Brenda property - MSN
Stifel Nicolaus Cuts Sight Sciences (NASDAQ:SGHT) Price Target to $5.00 - MarketBeat
Dry Eye Treatment Devices Market Poised to Attain Valuation of US$ 898.78 Million By 2033 | Pharmacological Synergy Driving Demand for Advanced Dry Eye Treatment Devices Says Astute Analytica - GlobeNewswire Inc.
Stifel Nicolaus Issues Pessimistic Forecast for Sight Sciences (NASDAQ:SGHT) Stock Price - Defense World
Life Sciences Group Of The Year: Cooley - Law360
What 6 Analyst Ratings Have To Say About Sight Sciences - Benzinga
Silexion Therapeutics announces exercise of warrants for $3.3M gross proceeds - MSN
Sight Sciences executives receive salary increases and bonus targets By Investing.com - Investing.com Nigeria
Sight Sciences executives receive salary increases and bonus targets - MSN
JPMorgan Chase & Co. Acquires 53,658 Shares of Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World
Sight Sciences Enhances Executive Compensation for 2025 - TipRanks
Sight Sciences price target lowered to $5 from $5.50 at UBS - MSN
Sight Sciences (NASDAQ:SGHT) Price Target Cut to $5.00 by Analysts at UBS Group - Defense World
UBS Group Cuts Sight Sciences (NASDAQ:SGHT) Price Target to $5.00 - MarketBeat
Sight Sciences, Inc. (NASDAQ:SGHT) Receives $4.72 Average PT from Analysts - MarketBeat
The Hain Celestial Group, Inc. (NASDAQ:HAIN) Receives Consensus Recommendation of “Hold” from Analysts - Defense World
Sight Sciences, Inc. (NASDAQ:SGHT) Given Average Recommendation of “Hold” by Brokerages - Defense World
Promising US Penny Stocks To Consider In January 2025 - Simply Wall St
Have Sight Sciences Insiders Been Selling Stock? - Simply Wall St
Long Focus Capital Management, LLC Increases Stake in Sight Scie - GuruFocus.com
Sight Sciences, Inc. (NASDAQ:SGHT) CEO Sells $72,471.48 in Stock - MarketBeat
Insider Selling: Sight Sciences, Inc. (NASDAQ:SGHT) Insider Sells 6,922 Shares of Stock - MarketBeat
Insider Selling: Sight Sciences, Inc. (NASDAQ:SGHT) CTO Sells 5,423 Shares of Stock - MarketBeat
Sight sciences CEO Paul Badawi sells shares worth $72,570 - MSN
Sight sciences CEO Paul Badawi sells shares worth $72,570 By Investing.com - Investing.com Australia
Sight sciences chief legal officer sells shares worth $19,250 - MSN
Sight sciences CTO David Badawi sells $15,081 in stock By Investing.com - Investing.com Australia
Sight sciences chief legal officer sells shares worth $19,250 By Investing.com - Investing.com South Africa
Sight Sciences Inc (SGHT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.10%
0.57%
자본화:
|
볼륨(24시간):